NCT06489301 Mechanisms for Laser-Induced Rejuvenation
| NCT ID | NCT06489301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wright State University |
| Condition | Skin Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2025-07-16 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2025-07-16 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It has shown that laser wounding of geriatric skin protects it against skin cancer. The purpose of this study is to determine the origin of cells called fibroblasts which are present after treatment with Fractionated Laser Resurfacing (FLR). These cells restore a youth-like ultraviolet B (UVB) response, but where they come from is currently unknown. The study recruits subjects who are scheduled to undergo abdominoplasties to investigate the origin of those cells stimulated by laser treatment.
Eligibility Criteria
Inclusion Criteria: * Adult males and females 18 and older * Able to comprehend procedures and risks * Planning to undergo abdominoplasty surgery * Minimum amount of skin to be removed is 50 x 20cm Exclusion Criteria: * Medical history of not well-controlled diabetes. This is defined as a subject who needs high doses of insulin, recent history of hospitalization for diabetes-related complications, or poor wound health as evidenced by diabetic ulcers. Subjects who have been deemed healthy enough for abdominoplasty surgery would tend to suggest that their diabetes should not be an issue. However, if the subjects have diabetic complications as outlined above, they could affect the wound healing which is the object of this protocol so they would be excluded. * Pregnant or nursing * History of pathologically abnormal wound healing such as keloidal scars * Existing tattoos on the abdomen that are so extensive that they could interfere with the study
Contact & Investigator
Jeffrey Travers, MD, PhD
PRINCIPAL INVESTIGATOR
Wright State University
Frequently Asked Questions
Who can join the NCT06489301 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06489301 currently recruiting?
Yes, NCT06489301 is actively recruiting participants. Contact the research team at pturesearch@wrightstatephysicians.org for enrollment information.
Where is the NCT06489301 trial being conducted?
This trial is being conducted at Fairborn, United States.
Who is sponsoring the NCT06489301 clinical trial?
NCT06489301 is sponsored by Wright State University. The principal investigator is Jeffrey Travers, MD, PhD at Wright State University. The trial plans to enroll 12 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.